| Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial P Harter, A Bois, M Hahmann, A Hasenburg, A Burges, S Loibl, M Gropp, ... Annals of surgical oncology 13, 1702-1710, 2006 | 549 | 2006 |
| A risk model for secondary cytoreductive surgery in recurrent ovarian cancer: an evidence-based proposal for patient selection WJ Tian, DS Chi, J Sehouli, CG Tropé, R Jiang, A Ayhan, G Cormio, ... Annals of surgical oncology 19, 597-604, 2012 | 140 | 2012 |
| Neoadjuvant chemotherapy shows similar response in patients with inflammatory or locally advanced breast cancer when compared with operable breast cancer: a secondary analysis … SD Costa, S Loibl, M Kaufmann, DM Zahm, J Hilfrich, J Huober, ... J Clin Oncol 28 (1), 83-91, 2010 | 83 | 2010 |
| Randomised trial: survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer S Kümmel, J Krocker, A Kohls, GP Breitbach, G Morack, M Budner, ... British journal of cancer 94 (9), 1237-1244, 2006 | 67 | 2006 |
| Uterine leiomyosarcoma I Juhasz-Böss, L Gabriel, RM Bohle, LC Horn, EF Solomayer, ... Oncology research and treatment 41 (11), 680-686, 2018 | 65 | 2018 |
| Neoadjuvant chemotherapy with carboplatin and docetaxel in advanced ovarian cancer-a prospective multicenter phase II trial (PRIMOVAR) M Pölcher, S Mahner, O Ortmann, J Hilfrich, K Diedrich, GP Breitbach, ... Oncology reports 22 (3), 605-613, 2009 | 57 | 2009 |
| Influence of side-effects on early therapy persistence with letrozole in post-menopausal patients with early breast cancer: Results of the prospective EvAluate-TM study N Nabieva, T Fehm, L Haeberle, J de Waal, M Rezai, B Baier, G Baake, ... European journal of cancer 96, 82-90, 2018 | 49 | 2018 |
| Influence of patient and tumor characteristics on early therapy persistence with letrozole in postmenopausal women with early breast cancer: results of the prospective Evaluate … N Nabieva, S Kellner, T Fehm, L Haeberle, J de Waal, M Rezai, B Baier, ... Annals of Oncology 29 (1), 186-192, 2018 | 42 | 2018 |
| Phase II study of fulvestrant 250 mg/month in patients with recurrent or metastatic endometrial cancer: A study of the Arbeitsgemeinschaft Gynäkologische Onkologie G Emons, A Günthert, FC Thiel, O Camara, HG Strauss, GP Breitbach, ... Gynecologic oncology 129 (3), 495-499, 2013 | 41 | 2013 |
| Continual oral versus intravenous interval therapy with bisphosphonates in patients with breast cancer and bone metastases IJ Diel, N Marschner, M Kindler, O Lange, M Untch, HJ Hurtz, ... Proc Annu Meet Am Soc Clin Oncol 488, 1999 | 38 | 1999 |
| Interest in integrative medicine among postmenopausal hormone receptor–positive breast cancer patients in the EvAluate-TM Study CC Hack, PA Fasching, T Fehm, J de Waal, M Rezai, B Baier, G Baake, ... Integrative cancer therapies 16 (2), 165-175, 2017 | 30 | 2017 |
| Gemcitabine combined with cisplatin as first-line treatment in patients 60 years or older with epithelial ovarian cancer: a phase II study T Bauknecht, A Hefti, G Morack, C Villena-Heinsen, D Wallwiener, ... International Journal of Gynecologic Cancer 13 (2), 2003 | 24 | 2003 |
| Gemcitabine in combination with cisplatin in previously untreated patients 60 years with FIGO stage IIIC or IV epithelial ovarian cancer: A phase II study: Preliminary results T Bauknecht, CH Grieshaber, GP Breitbach, C Villena-Heinson, ... PROCEEDINGS OF THE ANNUAL MEETING-AMERICAN SOCIETY OF CLINICAL ONCOLOGY 17 …, 1998 | 20 | 1998 |
| Arbeitsgemeinschaft gynaekologische onkologie ovarian committee; AGO ovarian cancer study group. Surgery in recurrent ovarian cancer: the arbeitsgemeinschaft Gynaekologische … P Harter, A du Bois, M Hahmann, A Hasenburg, A Burges, S Loibl, ... Ann Surg Oncol 13 (12), 1702-1710, 2006 | 18 | 2006 |
| Uterine rupture—an analysis of 81 cases in Conakry/Guinea MD Balde, GP Breitbach, G Bastert International Journal of Gynecology & Obstetrics 32 (3), 223-227, 1990 | 17 | 1990 |
| Factors influencing the time to surgery after neoadjuvant chemotherapy in breast cancer patients C Müller, I Juhasz-Böss, G Schmidt, P Jungmann, EF Solomayer, ... Archives of Gynecology and Obstetrics 301, 1055-1059, 2020 | 16 | 2020 |
| Treosulfan in the treatment of advanced ovarian cancer: a randomised co-operative multicentre phase III-study. GP Breitbach, H Meden, H Schmid, W Kühn, G Sass, S Schach, ... Anticancer research 22 (5), 2923-2932, 2002 | 16 | 2002 |
| Evaluation of therapy management and patient compliance in postmenopausal patients with hormone receptor-positive breast cancer receiving letrozole treatment: the EvaluateTM study PA Fasching, T Fehm, S Kellner, J de Waal, M Rezai, B Baier, G Baake, ... Geburtshilfe und Frauenheilkunde 74 (12), 1137-1143, 2014 | 15 | 2014 |
| Pre-operative selection criteria for operability in recurrent ovarian cancer. A study of the AGO Organkommission Ovar and the AGO Ovarian Cancer Study Group (AGO-OVAR) P Harter, GP Breitbach, B Tanner, J Sehouli, V Heilmann, HJ Lueck, ... Journal of Clinical Oncology 23 (16_suppl), 5004-5004, 2005 | 13 | 2005 |
| Borderline tumors of the ovary F Kommoss, B Richter, GP Breitbach Der Gynäkologe 34, 1003-1012, 2001 | 13 | 2001 |
